Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

novartis_outside_1

FDA approves Novartis’ Zykadia as first-line lung cancer treatment

May 30, 2017 Manufacturing and Production, Sales and Marketing FDA, NSCLC, Novartis

The FDA has announced it has approved Novartis’ Zykadia (ceritinib) as a first line treatment in the expanded indication of …
News

Global Pricing Innovations and Pricing360 announce new strategic partnership

May 30, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

London, May 30, 2017 – Global Pricing Innovations (GPI), the pricing and intelligence experts for the life sciences industry and …
News
Press release
dr

WHO elects first African Director General

May 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing WHO, appointment

Ethiopian-born Tedros Adhanom Ghebreyesus has been announced as the Next Director General of the World Health Organization (WHO) after securing …
Appointment

New FDA Commissioner reveals strategy to drive down drug prices

May 26, 2017 Manufacturing and Production, Sales and Marketing FDA, Scott Gottlieb, Trump, pricing

Deregulation, faster access and cheaper drug prices very quickly became the rallying cry for the Trump administration in the life …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

May 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

Among other things, it’s been a week characterised by safety failures as three of our most popular stories centred on …
News
breast_cancer

Puma Biotech’s breast cancer drug gets FDA committee nod

May 25, 2017 Medical Communications, Sales and Marketing Puma Biotech, breast cancer, neratinib

Puma Biotechnology breast cancer drug that could be used to reduce the risk of disease recurrence has been boosted by …
News
liz-new_photo_-_may_2016_jpeg_small

Pharmaceutical companies and patient advocacy groups: Natural allies in the support of patients

May 25, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, Takeda oncology, patient advocacy

As published in the special Market Access section of the latest issue of Pharmafocus, Liz Lewis, Chief Counsel & Compliance …
Feature
shutterstock_212432119

Neurocrine’s Ingrezza flops in Tourette’s for second time

May 25, 2017 Research and Development, Sales and Marketing Neurocrine Biosciences, tourette's

Neurocrine’s Tourette’s therapy Ingrezza (valbenazine) has been hit with yet another setback, flopping in a Phase 2 trial of paediatric …
News
abbottweb

26 die after attempting to replace Abbott’s blood pump controller themselves

May 24, 2017 Medical Communications, Sales and Marketing Abbott, FDA, Medical device, deaths

At least 26 advanced heart failure patients have died and 19 have been injured by attempting to change the controller …
News
keytruda3-web

MSD receives first FDA approval based on specific genetic feature

May 24, 2017 Research and Development, Sales and Marketing MSD, Precision Medicine, biomarker, keytruda

In a historic first, MSD (known as Merck in North America) has received approval for its immunotherapy treatment Keytruda in …
News
merckincweb1

MSD under CMA investigation over unfair Remicade pricing

May 24, 2017 Research and Development, Sales and Marketing Competition and Marketing Authority, MSD, Remicade

MSD is facing legal trouble after the Competition and Marketing Authority (CMA) alleged that the pharmaceutical firm had engaged in …
News
pharmafocus_june_2017_cover

The June 2017 issue of Pharmafocus is now live!

May 23, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Pharmafocus, Roche, Takeda, UK, brexit, data management, market access, neurological disorders

The latest edition of Pharmafocus is available to read online now!
News

European approval for novel Eisai epilepsy monotherapy

May 23, 2017 Research and Development, Sales and Marketing Bial, Eisai, Zebinix, epilepsy

Eisai and Bial have revealed that their drug Zebinix (eslicarbazepine acetate) has been awarded marketing authorisation by the European Commission …
News
2919193_kenneth

Nativis Incorporated appoints new CSO

May 23, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nativis

Nativis, a clinical stage life science bio-clectronic company, has appointed Dr Kenneth Ferguson to the position of Chief Scientific Officer. …
Appointment

Sanofi and Regeneron score FDA approval for arthritis

May 23, 2017 Manufacturing and Production, Sales and Marketing FDA, Kevzara, arthritis, sarilumab

The FDA has awarded Sanofi and Regeneron’s Kevzara (sarilumab) approval for the treatment of moderate to severely active rheumatoid arthritis …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026